Immune aberrations in B and T lymphocytes derived from chronic urticaria patients

被引:49
作者
Toubi, E [1 ]
Adir-Shani, A [1 ]
Kessel, A [1 ]
Shmuel, Z [1 ]
Sabo, E [1 ]
Hacham, H [1 ]
机构
[1] Bnai Zion Med Ctr, Div Clin Immunol & Allergy, Haifa, Israel
关键词
chronic urticaria; contact dermatitis; autoimmunity; bcl-2; proliferation;
D O I
10.1023/A:1006624331022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the pathophysiology of chronic urticaria (CU) in light of the abundant evidences that it is an autoimmune disease and to define some cellular markers in B/T lymphocytes that could be of pathogenic significance, we investigated 14 patients suffering from CU, compared to 7 contact dermatitis patients and 10 normal control individuals. We tested the expression of CD5, B7.1 (CD80), CD23, and CD25 on B cells and of CD40L and CD25 on T cells from all studied individuals. We also tested B cell proliferation upon their activation followed by dexamethazone induced inhibition of proliferation. The expression of bcl-2 protein in activated lymphocytes from normal individuals was compared to that of contact dermatitis and CU patients. CD40L expression was found significantly higher on in vitro activated CD3 [with phorbol myristate acetate (PMA) and ionomycine Ca2+ at 12 hr of culture] from CU patients compared to that of contact dermatitis and normal individuals. Whereas the proliferation of activated B cells from CU patients was higher, dexamethazone-induced inhibition of B cell proliferation was found statistically similar in both groups yet lower in B cells from most severe CU patients. We demonstrate a higher bcl-2 expression in activated B and T lymphocytes of severe CU patients compared to that of moderate CU and both contact dermatitis and normal individuals. The increased expression of CD40L on activated T cells might play a role in the polyclonal increased B cell proliferation of CU patients. This increased proliferation accompanies the finding that activated B and T lymphocytes from these patients demonstrate increased bcl-2 expression. The resistance of some B cells to dexamethazone-induced inhibition of proliferation encourages us to investigate the possibility that B cells from some CU patients might develop rescue mechanisms from activated cell death. These findings provide further evidence that CU is indeed an autoimmune disease, although its precise nature has yet to be fully elucidated.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 22 条
[11]   Chronic urticaria and angioedema associated with thyroid autoimmunity: Review and therapeutic implications [J].
Heymann, WR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (02) :229-232
[12]   THE PATHOGENESIS OF CHRONIC IDIOPATHIC URTICARIA - NEW EVIDENCE SUGGESTS AN AUTOIMMUNE BASIS AND IMPLICATIONS FOR TREATMENT [J].
HIDE, M ;
FRANCIS, DM ;
GRATTAN, CEH ;
BARR, RM ;
WINKELMANN, RK ;
GREAVES, MW .
CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (07) :624-627
[13]   AUTOANTIBODIES AGAINST THE HIGH-AFFINITY IGE RECEPTOR AS A CAUSE OF HISTAMINE-RELEASE IN CHRONIC URTICARIA [J].
HIDE, M ;
FRANCIS, DM ;
GRATTAN, CEH ;
HAKIMI, J ;
KOCHAN, JP ;
GREAVES, MW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1599-1604
[14]   Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes [J].
Koshy, M ;
Berger, D ;
Crow, MK .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :826-837
[15]  
Martin B L, 1999, J Am Osteopath Assoc, V99, pS1, DOI 10.7556/jaoa.1999.99.3.S1
[16]  
Leznoff A, 1998, CAN FAM PHYSICIAN, V44, P2170
[17]   Etiologic aspects of chronic urticaria [J].
Liutu, M ;
Kalimo, K ;
Uksila, J ;
Kalimo, H .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (07) :515-519
[18]  
Marone G, 1999, CLIN EXP ALLERGY, V29, P17
[19]   Assessment of autoimmunity in patients with chronic urticaria [J].
Tong, LJ ;
Balakrishnan, G ;
Kochan, JP ;
Kinet, JP ;
Kaplan, AP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (04) :461-465
[20]   Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria [J].
Toubi, E ;
Blant, A ;
Kessel, A ;
Golan, TD .
ALLERGY, 1997, 52 (03) :312-316